Clinical Trial Update: Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness of a COVID-19 vaccine in patients who have undergone hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Hematopoietic Stem Cell Transplantation (HSCT), COVID-19 Vaccines | Phase 2 | Status: UNKNOWN